There were 159 press releases posted in the last 24 hours and 467,178 in the last 365 days.

Cancer Immunotherapy: Advancing and Accelerating Discovery Programs, New Webinar Hosted by Xtalks

/ -- TORONTO, ON--(Marketwired - January 12, 2016) - As novel cancer immunotherapy treatments continue to be at the forefront of discovery and development, checkpoint inhibitor treatment remains center stage. Moreover, other targeted and personalized treatment modalities will likely emerge. Central to this effort will be a reliance on appropriate preclinical models, which form the backbone of many immuno-oncology drug discovery programs, particularly with the increasing focus on combination therapy. In-depth efficacy studies are a valuable source of in vivo information and will play a prominent role in elucidating potential compounds, either alone or in combination, that demonstrate potential as immunotherapeutic anti-cancer agents.

This webinar, featuring industry expert Joseph Murphy, PhD, Director of Oncology R&D at Charles River Laboratories, as the presenter, will provide an evaluation of several syngeneic murine tumor models to antibody-based, immune checkpoint inhibitor therapeutics. In addition, findings detailing the benefits of a multidisciplinary approach to cancer immunotherapy efficacy study design and execution will be outlined. The live broadcast takes place on Monday, January 25, 2016 at 11am EST (4pm GMT).

To learn more about this event visit: Cancer Immunotherapy: Advancing and Accelerating Discovery Programs.

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global Life Sciences community. Every year thousands of industry practitioners (from pharmaceutical & biotech companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit

For information about hosting a webinar visit

Image Available:

Dian Razak
Tel: +1 (416) 977-6555 ext 352

As your scientific partner and preclinical CRO provider, Charles River provides innovation, flexibility, and efficiency in IND-enabling studies from early discovery research and in vivo pharmacology models through safety assessment